Necrolytic migratory erythema: a report of three cases (Q72740393)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Necrolytic migratory erythema: a report of three cases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

K Thorisdottir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

C Camisa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

K J Tomecki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

W F Bergfeld

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 February 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

2 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

324-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

CUTANEOUS MANIFESTATIONS OF INTERNAL MALIGNANT TUMORS

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

The glucagonoma syndrome: clinical features, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

A glucagonoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Glucagonoma syndrome. Report of two cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Glucagonoma Syndrome: Case Report and Literature Review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Clinical and metabolic aspects of glucagonoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: Is hepatic impairment a clue to pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Necrolytic migratory erythema without glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Necrolytic Migratory Erythema Without Glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Necrolytic migratory erythema-like dermatitis with malabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Necrolytic migratory erythema without glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

The glucagonoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Extractable glucagon of the human pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Amino Acid Deficiency and the Skin Rash Associated with Glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Letter: Zinc deficiency and skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Rapid improvement of skin lesions in glucagonomas with intravenous somatostatin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Effect of somatostatin in necrolytic migratory erythema of glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

Pancreatic Endocrine Tumors — The Search Goes On

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2894%2970033-8

7 January 2021

10.1016/S0190-9622(94)70033-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8294591%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference